Resources – Page 6 – George Clinical


George Clinical Grows European Presence with New Location in the United Kingdom

LONDON, August 19, 2019 – George Clinical, a global scientifically-backed clinical research organization (CRO), has expanded its presence in Europe with the opening of a larger and more sophisticated location in the United Kingdom.  The office is based in London and compliments the organization’s growing list of global locations throughout the Asia-Pacific region, the United […]

Read More

September 17th, 2019

The George Institute and UNSW Founders Build Ecosystem for Health Innovations

In what could come as a big boost to entrepreneurs working to promote healthcare through innovations across the globe, University of New South Wales—Sydney and The George Institute for Global Health (TGI) have joined forces to launch a program dubbed Health10x designed to accelerate and scale up health focused start-ups. The Health10x program was conceived […]

Read More

September 11th, 2019

Professor Bruce Neal Appointed Executive Director of The George Institute

George Clinical is pleased to announce that Dr. Bruce Neal has been appointed Executive Director of The George Institute Australia effective September 1.   Neal was a founding member of the Institute, together with John Chalmers and Principal Directors Stephen MacMahon and Robyn Norton.  Neal has contributed to the growth of the Institute across many areas […]

Read More

September 5th, 2019

WHO Endorsement of Simpler Drug Treatment for Blood Pressure Will Improve Treatment Availability for 1 Billion People

George Clinical welcomes the addition of fixed dose combinations (FDCs) of blood pressure (BP) lowering drugs to the World Health Organization (WHO) Essential Medicines List (EML) in response to an application filed by Resolve to Save Lives (RTSL), an initiative of vital strategies, The George Institute and other partners. Adding FDCs of blood pressure lowering […]

Read More

July 31st, 2019

The George Institute Researchers Find Diabetes Increases the Risk of Heart Failure for Women at a Higher Rate

A global study of 12 million people has found diabetes increases the risk of heart failure and this increase is greater for women than men.  Researchers from The George Institute for Global Health determined that this differential was greater in Type 1 than Type 2 diabetes. Type 1 diabetes is associated with a 47% excess […]

Read More

July 19th, 2019

Big and Small Pharma Enjoy a Significant Opportunity to Leverage India for Trials

The Indian subcontinent deserves to be considered by pharmaceutical or biotech firms examining clinical trial locations, and veteran industry players may be surprised to learn India is already a leading destination for global clinical trials with significant growth taking place in the biotech sector.   Prime opportunities exist for all phases of clinical trials due to […]

Read More

July 17th, 2019

Award Highlights George Clinical as Leading Employer in Asia-Pacific Region

Last year George Clinical gained recognition by the Mandatory Provident Fund (MPF) legislation for their provision of good MPF benefits in Hong Kong.  The Mandatory Provident Fund Schemes Authority (MPFA) awarded George Clinical their Good MPF Employer Award at a ceremony in Hong Kong where Evon Hui, Head of Business Operations, East Asia, accepted the […]

Read More

July 13th, 2019

George Clinical Welcomes FDA Framework for Real World Evidence Program

December of 2018 saw the FDA release their “Framework For Evaluating the Potential Use of Real-World Evidence (RWE)” to support the approval of a new indication for a drug already approved under section 505(c) of the FD&C Act.  This document was developed to outline guidance and support of real world data collection efforts for post-approval […]

Read More

June 1st, 2019

CTTI Recommendations Developed to Improve Engagement in Mobile Clinical Trials

George Clinical is proud to have been involved in developing the recently announced recommendations by the Clinical Trial Transformation Initiative (CTTI): The Recommendations for Engaging Patients and Sites in Mobile Clinical Trials. The recommendations, to which George Clinical contributed as a member on the expert committee, aim to help research organizations, sponsors, and other stakeholders […]

Read More

June 1st, 2019

George Clinical Expands Asia-Pacific Footprint with New Location in the Philippines

SYDNEY, May 29, 2019 – George Clinical, a global scientifically-backed clinical research organization (CRO), has again expanded its extensive Asia-Pacific footprint through the opening of a new office in the Philippines.  The office is based in the capital city, Manila and compliments the organization’s growing list of global locations.   The opening of this office […]

Read More

May 29th, 2019